New psoriasis treatment can cut risk of heart attack and stroke

   Mar 17, 3:22 pm

Washington, March 17 (ANI): A new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease, a new study has revealed.

Psoriasis is a chronic inflammatory disease of the skin and joints that affects up to 3 percent of the population.

This disease is associated with a greater risk of heart attack (infarction) and stroke.

The study co-led by the Montreal Heart Institute and Innovaderm Research Inc., wanted to show that a treatment to reduce skin inflammation in psoriasis patients could be associated with a decrease in vascular inflammation.

The study had positive results, as vascular inflammation decreased significantly in patients suffering from psoriasis who were treated with adalimumab, a biological anti-inflammatory compound.

The study also showed a 51percent decrease in C-reactive protein among patients treated with adalimumab compared to a 2 percent decrease among patients in the control group.

These results are significant, as a high level of C-reactive protein is known to be associated with an increased risk of heart attack and stroke.

In relation to the treatment of psoriasis, 70 percent of patients who received the compound presented with a major decrease in skin lesion severity, compared to 20 percent of patients in the control group.

"This study is a great example of the high-level research being conducted in Montreal," said Dr. Robert Bissonnette, President and Founder of Innovaderm Research Inc. and co-principal author of the study.

He added that this clinical research study suggests that it is possible to assess the impact of psoriasis treatments on the heart without having to resort to long-term studies that require thousands of patients and have higher costs.

"These findings are extremely encouraging for people suffering from psoriasis, as they face a greater risk of cardiovascular disease," explained Dr. Jean-Claude Tardif, Director of the Research Centre of the Montreal Heart Institute and co-principal author of the study.

He also emphasized the importance of regular medical follow-up for people with psoriasis to prevent cardiovascular events and establish an optimum therapeutic approach.

The finding was presented today at the annual meeting of the American Academy of Dermatology. (ANI)

Cooking gas stoves at home associated with childhood asthma Sep 30, 5:31 pm
Washington, Sept 30 (ANI): Scientists have found that ventilation while cooking with a gas stove is essential, as the lack of it was linked to childhood asthma.
Full Story
Opioid painkillers carry high risk of addiction, even death Sep 30, 4:18 pm
Washington, Sept 30 (ANI): A new research has revealed that opioid painkillers carry higher risk of death, overdose, addiction or serious side effects than benefits in chronic, non-cancer conditions like headache, fibromyalgia and chronic low back pain.
Full Story
Avigan Tablet 200mg administered to a French woman infected with Ebola virus Sep 30, 4:18 pm
Tokyo, Sept.30 (ANI): FUJIFILM Corporation announced that the anti-influenza drug 'Avigan(r) Tablet 200mg' (Favipiravir), developed by the Fujifilm Group company Toyama Chemical Co., Ltd, has been administered to a patient infected with the Ebola virus disease at a hospital in France.
Full Story
Eating apples helps prevent obesity disorders Sep 30, 2:39 pm
Washington, Sept 30 (ANI): A new study has examined that nondigestible compounds in apples may help prevent disorders associated with obesity.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY